Investigation of the outpatient chemotherapy for lung cancer patients in Tokushima University Hospital

Hisatsugu Goto(Tokushima University), Yasuhiko Nishioka(Tokushima University), Masahiko Azuma(Tokushima University), Hideki Tomimoto(Tokushima University), Yukiyo Miki(Tokushima University Hospital), Toshifumi Tezuka(Tokushima University), Masaki Hanibuchi(Tokushima University), Toshimi Nakamura(Tokushima University Hospital), Takanori Kanematsu(Matsuyama Red Cross Hospital), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Satoshi Sakaguchi(Tokushima University Hospital), Saburo Sone(Io Therapeutics (United States)), Hiroya Tada(Tokushima University)
The Journal of Medical Investigation
January 1, 2011
10.2152/jmi.58.219
Cited by 1

Related Papers

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
|Oncogene|2003|324
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer
|Cancer Research|2006|134
Plakophilin 3 Oncogene as Prognostic Marker and Therapeutic Target for Lung Cancer
|Cancer Research|2005|124